John Paulson’s Paulson & Co. disclosed in an SEC filing its holdings as of March 31, 2026. Paulson’s one new buy during the first quarter was Amicus (FOLD). Paulson exited one position during the quarter, Solstice Advanced Materials (SOLS). Paulson increased its stake in two holdings, including by size of previous position, International Tower Hill Mines (THM) and Thryv Holdings (THRY). Paulson reduced its stake in one holding, Madrigal Pharma (MDGL). Paulson’s top holdings as of March 31, in order of size, were Perpetua Resources (PPTA), Madrigal Pharma, Acadian Asset Management (AAMI), Bausch Health (BHC), and Novagold Resources (NG).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLS:
- Solstice Advanced Materials downgraded to Hold from Buy at Vertical Research
- Solstice Advanced Materials downgraded to Hold at Vertical Research on valuation
- Solstice Advanced Materials price target raised to $88 from $87 at UBS
- Solstice Advanced Materials price target raised to $85 from $80 at JPMorgan
- Solstice Advanced Materials reports Q1 adjusted EPS 63c, consensus 61c